Don't Rely on Pregnancy Letter Categories to Make Treatment Recommendations

Pregnancy categories (A, B, C, D, X) will start to DISAPPEAR from Rx drug labels...due to new rules on reporting pregnancy and lactation risks.

It's been a long time coming...over 20 years since FDA's labeling change initiative began. Now it's finally starting to hit drug labels.

More relevant info to help with therapy decisions will replace the A, B, C, D, and X categories...because these "letters" oversimplify and don't consistently explain the degree of fetal risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote